Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Lodoxamide ethyl
Lodoxamide ethyl
  • Lodoxamide ethyl

Lodoxamide ethyl NEW

Price $85 $210 $310
Package 1mg 5mg 10mg
Min. Order:
Supply Ability: 10g
Update Time: 2024-11-19

Product Details

Product Name: Lodoxamide ethyl CAS No.: 53882-13-6
Purity: 99.48% Supply Ability: 10g
Release date: 2024/11/19

Product Introduction

Bioactivity

NameLodoxamide ethyl
Descriptionlodoxamide ethyl is a new orally active anti-allergic compound for the prevention of antigen-induced bronchoconstriction and blockage of skin allergic reactions.
StorageShipping with blue ice.
Solubility InformationDMSO : 50 mg/mL (135.97 mM)
Related Compound LibrariesBioactive Compound Library | Bioactive Compounds Library Max

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/200kg
VIP1Y
Qingdao RENAS Polymer Material Co., Ltd.
2024-08-22
$50.00/25kg
VIP1Y
Wuxi High Mountain Hi-tech Development Co.,Ltd.
2024-12-13
$6.00/1kg
VIP1Y
Hebei Longbang Technology Co., Ltd
2024-05-24
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hills
INQUIRY